Biotheranostics

December 16, 2019

Breast Cancer Index Identifies Women Likely to Benefit From Extended Hormone Therapy, Latest Data Show

News

The Breast Cancer Index, a molecular test developed by Biotheranostics, successfully identified a group of women with hormone receptor (HR)-positive breast cancer who may benefit from long-term hormone therapy with ... Read more

June 28, 2019

Breast Cancer Index Identifies Patients Who Will Benefit From Extended Endocrine Therapy, Data Shows

News

Biotheranostics‘ Breast Cancer Index can help distinguish which breast cancer patients will derive a benefit from prolonged endocrine therapy — allowing those who don’t to stop treatment and avoid its ... Read more